Chairs: S Ferrari, W Leslie

Members: B Abrahamsen, K Akesson, N Al-Daghri, E Biver, M Chakthoura, M Chandran, T Chevalley, R Eastell, G El Hajj Fuleihan, CC Glüer, B Josse, D Kendler, N Lane, P Makras, C Meier, A Mithal, N Napoli, A Suzuki, S Vasikaran

To give guidance on the diagnosis and management of osteoporosis in the context of diabetes.

TBS and microstructure alterations in diabetes in relation to bone fragility.

1. Meier, C., Eastell, R., Pierroz, D. D., Lane, N. E., Al-Daghri, N., Suzuki, A., Napoli, N., Mithal, A., Chakhtoura, M., El-Hajj Fuleihan, G., & Ferrari, S. (2023). Biochemical Markers of Bone Fragility in Patients With Diabetes. The Journal of Clinical Endocrinology & Metabolism, dgad255. https://doi.org/10.1210/clinem/dgad255
2. Ferrari SL, Abrahamsen B, Napoli N, Akesson K, Chandran M, Eastell R, El-Hajj Fuleihan G, Josse R, Kendler DL, Kraenzlin M, Suzuki A, Pierroz DD, Schwartz AV, Leslie WD, on behalf of the Bone and Diabetes Working Group of IOF. Diagnosis and Management of Bone Fragility in Diabetes: An Emerging Challenge – A Short Review. Journal of Diabetes Management and Metabolism, 2020. JDMM-10008
3. Ferrari, S.L., et al., Diagnosis and management of bone fragility in diabetes: an emerging challenge. Osteoporos Int, 2018. 29(12): p. 2585-2596.
4. Napoli, N., et al., Mechanisms of diabetes mellitus-induced bone fragility. Nat Rev Endocrinol, 2017. 13(4): p. 208-219.
5. Hough, F.S., et al., MECHANISMS IN ENDOCRINOLOGY: Mechanisms and evaluation of bone fragility in type 1 diabetes mellitus. Eur J Endocrinol, 2016. 174(4): p. R127-38.